Pregnancy Poses Challenges to MS Management, Review Study Shows
Women with multiple sclerosis (MS) who receive high-efficacy disease-modifying therapies (DMTs) before conception have a greater risk of…
Articles by Patricia Inacio, PhD
FDA Approves Lyvispah, Granular Form of Baclofen, to Treat Spasticity
The U.S. Food and Drug Administration (FDA) has approved Lyvispah, a dissolvable granular formulation of baclofen, to treat…
Lucid-MS Restores Motor Function in Mouse Model, Company Says
Lucid-MS, a new chemical molecule being developed by FSD Pharma for the treatment of multiple sclerosis (MS), has…
$100K Grant Awarded to Study How Patients Are Adhering to Oral DMTs
A researcher at the University of Houston has received a $100,000 grant to investigate adherence to oral disease-modifying therapies (DMTs)…
Deal Brings AI-powered MRI to Care of Patients With Brain Disorders
A new collaboration between Arterys and Combinostics seeks to bring comprehensive artificial intelligence (AI) imaging solutions to the…
MS Society of Canada Urges Consistent Access to COVID-19 Boosters
The Multiple Sclerosis Society of Canada is urging that all provinces and territories in Canada offer COVID-19Â booster vaccines to…
Cerebellar Lesions in RRMS Linked to Worsening Manual Dexterity
The number of lesions affecting the cerebellum — a brain region responsible for coordinating voluntary movements and motor skills such…
Phase 3 Trials of Tolebrutinib in MS Forms to Include Digital Measures
Sanofi Genzyme has extended its collaboration with Koneksa to bring digital measures into its Phase 3 trials…
Ponvory Now Available in Scotland at Low or No Cost Through NHS
The Scottish Medicines Consortium (SMC) has recommended that Ponvory (ponesimod) be offered through the National Health Service (NHS) Scotland to people with active,…
Numares to Develop Multi-biomarker Test of SPMS Transition
Numares has signed an exclusive licensing agreement with Oxford University Innovation to develop and commercialize a panel of…
T20K Combo Shows Promise in MS Preclinical Studies
New preclinical data continues to support the potential of Cyxone’s investigational plant-derived peptide T20K for the treatment of…
Medsenic Being Granted US Patent for Arscimed for RRMS
The U.S. Patent and Trademark Office will grant Medsenic a patent covering the use of Arscimed, its investigational formulation…
Innodem, Novartis Team Up on Trial Testing Eye-tracking Technology
Innodem Neurosciences is teaming up with Novartis Canada on a breakthrough clinical trial to evaluate if Innodem’s digital…
NICE Opposes Ponvory Being Added to NHS for England and Wales
The National Institute for Health and Care Excellence (NICE) will not recommend that Ponvory (ponesimod) be added to the…
CALLIPER Trial for Progressive MS Enrolls First Patient
Immunic Therapeutics has enrolled the first patient in a Phase 2 clinical trial testing its oral therapy candidate IMU-838…
NervGen Brings Advanced Imaging to Planned NVG-291 Trials
A partnership will allow NervGen to use Imeka‘s proprietary biomarker imaging technology to precisely measure changes in the brain…
Alliance Calls for Accessible Products Design Down Under
The Accessible Product Design Alliance has released a statement calling for changes in products and packaging design to assure equal…
Roche, Temedica Launch Brisa App to Improve Lives of German Patients
Temedica, a Munich-based digital health company, has joined efforts with Roche to launch a free mobile app that…
i-Belong App Aims to Expand Online MS Patient Communities
Belong.Life has launched an app that allows health professionals to build and manage their own online communities of…
Moderate-to-severe Bowel Problems Found in 14.5% of Patients
Moderate-to-severe bowel dysfunction was detected in 14.5% of adult people with multiple sclerosis (MS), an Italian study reports. The…
MS Poses Challenge to Dating, Meeting People
Meeting people and dating is challenging for people with multiple sclerosis (MS), but the experience of dating is highly…
Third Phase 3 Trial of Sativex, Cannabis Extract for MS Spasticity, Planned
Jazz Pharmaceuticals is planning to open a third Phase 3 clinical trial of Sativex (nabiximols), an oral…
Amino Acid Metabolite Shows Anti-inflammatory Potential
A natural, small molecule called 3-HKA) has shown potent anti-inflammatory activity in lab tests and mouse models of immune-related diseases,…
Actively ‘Coping’ With Daily Stress of MS Tied to Better Life Quality
Actively taking steps to cope with the chronic stress of multiple sclerosis (MS) — from keeping a sense of…
3 UK Scientists Win Challenge Awards for Progressive MS Projects
Three scientists in the U.K. were given awards by the International Progressive MS Alliance that will support projects aiming to…
Ibudilast, Potential Progressive MS Therapy, Awaits US Patent
MediciNova announced that it will be given a U.S. patent covering the use of ibudilast (MN-166) in treating eye…
Sativex Eased MS Spasticity as an Add-on Therapy
Sativex (nabiximols), an oral spray that contains cannabis extracts, was found effective as an add-on therapy for easing…
Progressive MS Projects Earn Research Challenge Awards
The Multiple Sclerosis Society of Canada has granted its International Progressive MS Alliance (Alliance) Research Challenge Awards to 19…
Home-based Exercise Viable Alternative for RRMS Patients
A home-based rehabilitation program can help ease fatigue, improve motor and cognitive function, and promote better quality of life in…
Shepherd Center, BurnAlong Open Global Online Rehab Classes for MS
BurnAlong and the Shepherd Center, a leading rehabilitation hospital in the U.S., have established a partnership to bring tailored…